Dyne Therapeutics, Inc.
NASDAQ:DYN
Overview | Financials
Company Name | Dyne Therapeutics, Inc. |
Symbol | DYN |
Currency | USD |
Price | 28.48 |
Market Cap | 2,859,420,480 |
Dividend Yield | 0% |
52-week-range | 8.044 - 47.45 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joshua T. Brumm |
Website | https://www.dyne-tx.com |
An error occurred while fetching data.
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD